Target intelligence / Profile preview

M protein of Streptococcus pyogenes (M protein)

Target
M protein
Molecular classification
Surface protein (bacterial), Virulence factor, Fibrillar coiled-coil protein, Other
01

Overview

The M protein of Streptococcus pyogenes is a surface-exposed, coiled-coil virulence protein that forms a dense fibrillar layer on the bacterial surface. It is anchored to the cell wall via a conserved LPXTG motif and sortase-mediated mechanism. The N-terminal region is highly variable among strains and determines serotype (e.g., M1, M3, etc.), while the C-terminal contains conserved anchoring motifs. It mediates immune evasion by blocking complement deposition, interfering with antibody binding (notably IgG Fc domains), binding host plasma proteins (e.g., factor H, fibrinogen, plasminogen), and promoting adhesion and inflammatory responses, enabling pharyngeal and invasive infections. M protein is the major target of the protective immune response, the principal antigen of Lancefield group A classification, and a key focus for multivalent vaccine strategies. However, its molecular mimicry of human tissue proteins underlies the pathogenesis of post-streptococcal autoimmune diseases, notably rheumatic fever.

Other names
Streptococcal M proteinGroup A Streptococcus M proteinGAS M proteinM1 protein
02

Mechanism of action

Vaccines: Induce production of protective antibodies that block the protein’s functions, enhance opsonization, and neutralize infection. Antibodies: Promote opsonization for immune clearance by macrophages and neutrophils, neutralize its immune evasion properties.

03

Biological functions

Immune evasion (anti-phagocytic action, interferes with complement system and antibody deposition)Adhesion to host tissuesFormation of microcoloniesBinding to host plasma proteins (e.g., Factor H, fibrinogen, plasminogen, immunoglobulin G)Triggering host inflammation (proinflammatory and procoagulatory states)Other
04

Disease associations

Infection (core role in pathogenesis of streptococcal pharyngitis, impetigo, scarlet fever, toxic shock syndrome, necrotizing fasciitis, acute post-streptococcal glomerulonephritis, rheumatic fever)Autoimmune conditions (molecular mimicry contributing to rheumatic fever and cross-reactivity)Other
05

Safety considerations

High antigenic variability (over 100 serotypes), complicating vaccine development and immune responsesRisk of autoimmune cross-reactivity (anti-M protein antibodies cross-react with heart/brain/skin tissue, contributing to rheumatic fever)Potential for strain escape or non-type-specific immunity due to variabilityOther
06

Interacting drugs

No FDA-approved drugs directly targeting M protein (as of August 2025).

2 more in the full profile.

07

Biomarkers

Detection of anti-M protein antibodies for diagnosis, epidemiology, or monitoring (e.g., in rheumatic fever)PCR and DNA sequencing of the M protein gene for strain typing and outbreak monitoringPresence of specific serotypes (M1, M3, M12, etc.) for surveillanceOther (e.g., use in epidemiological vaccines strategies)

Beyond the preview

Go deeper on M protein of Streptococcus pyogenes (M protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on M protein of Streptococcus pyogenes (M protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call